Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Pharmacology   Volumes    Volume 18 
Abstract
A possible novel pharmacological therapy for Parkinson’s disease using the pleiotropic property of Selegiline
Shin-ichi Ono, Ryuji Sone, Ei-ichi Tokuda
Pages: 29 - 37
Number of pages: 9
Current Topics in Pharmacology
Volume 18 

Copyright © 2014 Research Trends. All rights reserved

ABSTRACT
 
Monoamine oxidase type B (MAO-B) inhibitors have neuroprotective properties in addition to their primary pharmacologic function. We examined the effects of selegiline, an irreversible MAO-B inhibitor, on the expression levels of survivin mRNA and lipid peroxidation in the corpus striata of 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonian mice. Mice were treated with normal saline (vehicle as control), MPTP alone (30 mg/kg of body weight), MPTP with low-dose of selegiline (0.1 mg/kg of body weight), or MPTP with high-dose of selegiline (1.0 mg/kg of body weight). A consecutive 7-day oral treatment of MPTP alone did not influence survivin mRNA expression. Selegiline treatment together with MPTP significantly upregulated survivin expression at both low- and high-doses. Interestingly, lipid peroxidation was significantly suppressed by a low-dose of selegiline but not by a high-dose. These results suggest that selegiline has pleiotropic effects; the upregulation effects on survivin mRNA expression are likely to be independent from its primary pharmacological properties (MAO-B inhibition), whereas the inhibitory effects on lipid peroxidation seem to be associated with its primary pharmacological properties. In addition to conventional dopamine supplementation therapy, selegiline might serve as a novel pharmacological therapeutic strategy for Parkinson’s disease through its antiapoptotic properties via survivin induction as well as its antioxidative properties.
View Full Article  


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms